Guided Therapeutics (GTHP) Non-cash Items (2011 - 2025)

Guided Therapeutics has disclosed Non-cash Items across 15 years of filings, most recently posting $2.1 million for Q3 2025.

• Non-cash Items for Q3 2025 came in at $2.1 million, down 4.38% year-over-year; the trailing twelve-month figure through Sep 2025 was $2.1 million (down 4.38% YoY), and the FY2024 annual result was $1.9 million, up 6.21% from the prior year.
• Non-cash Items came in at $2.1 million for Q3 2025 at Guided Therapeutics, down from $2.2 million in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $2.4 million in Q1 2025 to a low of -$224000.0 in Q2 2021.
• The 5-year median for Non-cash Items is $1.9 million (2023), against an average of $1.7 million.
• Peak annual rise in Non-cash Items reached 127.81% in 2021, while the deepest fall reached 103.53% in 2021.
• Guided Therapeutics' Non-cash Items stood at -$224000.0 in 2021, then jumped by 688.43% to $1.3 million in 2022, then surged by 37.42% to $1.8 million in 2023, then gained by 6.21% to $1.9 million in 2024, then grew by 7.98% to $2.1 million in 2025.
• The last three Non-cash Items figures came in at $2.1 million (Q3 2025), $2.2 million (Q2 2025), and $2.4 million (Q1 2025), per Business Quant data.